Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Gene expression signatures for PMP treatment

ABSTRACT: Gene expression signatures for PMP treatment

PROVIDER: PRJNA638280 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Similar Datasets

Gene expression signatures for PMP treatment

Project description:To identify the genes inversely regulated by PMPs, we performed a microarray for global gene expression profiling in CB-MNCs with/without PMP treatment. In MNCs treated with PMPs, 129 genes were downregulated.

2020-09-07 | GSE152079 | GEO

Fludeoxyglucose F 18 PET Imaging in Determining Protein and Gene Expression Signatures in Patients With Premalignant Polyps or Colon Cancer

Project description:RATIONALE: Diagnostic imaging procedures, such as fludeoxyglucose F 18 PET, may be effective in detecting cancer or recurrence of cancer, or premalignant polyps. PURPOSE: This clinical trial is studying fludeoxyglucose F 18-PET imaging to see how well it works in determining protein and gene expression signatures in patients with premalignant polyps or colon cancer.

| 2045806 | ecrin-mdr-crc

Gene expression signatures for plumbagin (PL) treatment in OSCC cell lines

Project description:Gene expression signatures for plumbagin (PL) treatment in OSCC cell lines

| PRJNA777874 | ENA

Gene expression signatures for apigenin treatment in human AML cell lines

Project description:Gene expression signatures for apigenin treatment in human AML cell lines

| PRJNA798012 | ENA

Gene expression profiling study to identify molecular markers exhibiting distinct characteristics of Pseudomyxoma Peritonei [Fresh Frozen]

Project description:The purpose of this study is to evaluate gene expression changes and identify characteristics in patients with Pseudomyxoma Peritonei (PMP). We analyzed RNA-seq data to identify gene signatures associated with PMP development using 19 fresh frozen tissue samples including 12 PMPs (discovery cohort). Through analyzing the differences in gene expression between normal tissues and PMP, we identified statistically significant gene groups, and confirmed the biological functions and pathways associated with these gene groups.

2024-10-09 | GSE228376 | GEO

A gene expression profiling study to identify distinct molecular markers in formalin-fixed, paraffin-embedded samples of Pseudomyxoma Peritonei [FFPE]

Project description:The purpose of this study is to evaluate gene expression changes and identify characteristics in patients with Pseudomyxoma Peritonei (PMP). We analyzed RNA-seq data from 34 formalin-fixed paraffin-embedded (FFPE) samples, including 25 PMPs (validation cohort), to identify gene signatures associated with the development of PMP. We confirmed protein expression levels using a tissue microarray (TMA) cohort of PMP patients. Through analyzing the differences in gene expression between normal tissues and PMP, we identified statistically significant gene groups, and confirmed the biological functions and pathways associated with these gene groups.

2024-10-09 | GSE228375 | GEO

Gene expression signatures of healthy mouse skin after cold physical plasma treatment

Project description:Gene expression signatures of healthy mouse skin after cold physical plasma treatment

| PRJNA641021 | ENA

Gene expression signatures in multiple myeloma

Project description:Gene expression signatures in multiple myeloma

| PRJNA521958 | ENA

Gene expression signatures for lung adenocarcinoma

Project description:Gene expression signatures for lung adenocarcinoma

| PRJNA590980 | ENA

Gene expression signatures for Intrahepatic cholangiocarcinoma

Project description:Gene expression signatures for Intrahepatic cholangiocarcinoma